Equities

Sanofi Consumer Healthcare India Ltd

SANOFICONR:NSI

Sanofi Consumer Healthcare India Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)4,850.55
  • Today's Change5.55 / 0.11%
  • Shares traded3.81k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 04:52 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Income statement information is not available for Sanofi Consumer Healthcare India Ltd.
Gross margin71.64%
Net profit margin28.81%
Operating margin37.45%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in INRView more

SmartText is unavailable
Cash flow per share101.73
Price/Cash flow per share48.04
Book value per share80.15
Tangible book value per share77.94
More ▼

Balance sheet in INRView more

Sanofi Consumer Healthcare India Ltd has a Debt to Total Capital ratio of 9.86%.
Current ratio2.84
Quick ratio2.27
Total debt/total equity0.1094
Total debt/total capital0.0986
More ▼

Growth rates in INR

Growth rate information is not available.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
--
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.